管理患有牛皮和代谢性并发症的患者
Francesco Bellinato1, Martina Maurelli1, Davide Geat2
1Section of Dermatology and Venereology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy.
American journal of clinical dermatology
|May 15, 2024
概括
牛皮患者通常有代谢问题,如肥胖和糖尿病,影响治疗选择. 管理这些综合性疾病需要仔细选择药物和改变生活方式,以获得有效的护理.
科学领域:
- 皮肤病学 皮肤病学
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
背景情况:
- 牛皮与代谢并发症有关,如肥胖,高血压,糖尿病,脂质不良和NAFLD.
- 这些并发症会影响牛皮治疗的有效性和安全性.
- 药物相互作用和不良事件是共同管理患者的担忧.
研究的目的:
- 审查在患有代谢性并发病症的患者中治疗牛皮的挑战.
- 总结流行病学联系和病原遗传机制.
- 讨论药物的有效性,安全性和非药物干预措施.
主要方法:
- 流行病学数据的叙述性审查.
- 病原遗传机制的总结.
- 分析与代谢条件相关的常规和生物药物概况.
主要成果:
- 牛皮和代谢性疾病之间存在强烈的流行病学关联.
- 代谢性并发症需要谨慎的药物选择,因为有效性和安全性变化.
- 药理和非药理干预都至关重要.
结论:
- 管理牛皮与代谢性并发病症需要全面的方法.
- 量身定制的药理治疗是必不可少的.
- 个性化非药物干预,包括改变生活方式,对于最佳的患者结果至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
266
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
266
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
Chronic Pancreatitis II: Collaborative Care
85
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
85
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226


